Finasteride as a Treatment for Male Androgenetic Alopecia

    April 2013 in “ e-Jurnal Medika Udayana ”
    Ni Luh Putu Thrisna Dewi, I Wyn. Sugiritama
    Studysummary This abstract indicates that finasteride, at a dose of 1 mg per day, is effective in treating androgenetic alopecia in men by significantly reducing DHT levels.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ojs.unud.ac.id →
    Discuss this study in the Community →

    Related research 14

    1. A Review on Finasteride: A 5-Alpha Reductase Inhibitor, Its Mechanism, Facts, and Benefits Journal of Drug Delivery and Therapeutics · 2019
    2. Long-Term Treatment with Finasteride Induces Apoptosis and Pathological Changes in Female Mice Human & Experimental Toxicology · 2019
    3. Luncheon Symposium: Update on the Efficacy and Safety of Dutasteride in the Management of Androgenetic Alopecia 프로그램북(구 초록집) · 2015
    4. The Influence of Low Dose Finasteride, a Type II 5α-Reductase Inhibitor, on Circulating Neuroactive Steroids Hormone Molecular Biology and Clinical Investigation · 2009
    5. Finasteride Treatment and Neuroactive Steroid Formation PubMed · 2009
    6. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006
    7. Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women Dermatology · 2004
    8. Influence of Estrogens on Androgen Metabolism in Different Subunits of Human Hair Follicles PubMed · 2001
    9. 5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia International Journal of Cosmetic Surgery and Aesthetic Dermatology · 2001
    10. Effects of the Anti-Androgen Finasteride on 5-Alpha-Reductase Activity in Human Gingival Fibroblasts in Response to Minocycline Journal of Clinical Periodontology · 1998
    11. Prevalent Decrease of the EGF Content in the Periurethral Zone of BPH Tissue Induced by Treatment with Finasteride or Flutamide PubMed · 1997
    12. Finasteride: A New Drug for the Treatment of Male Hirsutism and Androgenetic Alopecia? PubMed · 1996
    13. Clinical Pharmacokinetics and Pharmacodynamics of Finasteride Clinical Pharmacokinectics · 1996
    14. Finasteride: A 5 Alpha-Reductase Inhibitor PubMed · 1993